
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$294.8m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.71
7D
1.4%
1Y
716.1%
Neuren Pharmaceuticals
Market Cap: AU$2.2b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$17.65
7D
36.8%
1Y
26.1%